Authors: Scheulen, ME Hilger, RA Oberhoff, C Casper, J F'reund, M Josten, KM Bornhauser, M Ehninger, G Berdel, WE Baumgart, J Harstrick, A Bojko, P Wolf, HH Schindler, AE Seeber, S

Citation: Me. Scheulen et al., Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies, CLIN CANC R, 6(11), 2000, pp. 4209-4216

Authors: Hilger, RA Jacek, G Oberhoff, C Kredtke, S Baumgart, J Seeber, S Scheulen, ME

Citation: Ra. Hilger et al., Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer, CANC CHEMOT, 45(6), 2000, pp. 483-488

Authors: Vanhoefer, U Muller, MR Hilger, RA Lindtner, B Klaassen, U Schleucher, N Rustum, YM Seeber, S Harstrick, A

Citation: U. Vanhoefer et al., Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines, BR J CANC, 81(8), 1999, pp. 1304-1310